Position
Director
Company
Verastem Oncology
NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
On October 12, 2026, Michael Bailey was appointed as President and Chief Executive Officer of Verastem, Inc., effective January 1, 2027. This appointment follows Daniel W. Paterson's decision to retire from the position, although he will remain on the Board as a Class III director
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
Who to call at Verastem Oncology, and when
A new leader at Verastem Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verastem Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verastem Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Verastem Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.